Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML
NCT01611116Phase 2Completed
- Sponsor
- Goethe University Frankfurt
- Start
- May 2012
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in acute myeloid leukemia (AML), sponsored by Goethe University Frankfurt. Started May 2012; status: completed.
02
Drugs
temsirolimus
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01611116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611116.